Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122447013 | 12244701 | 3 | F | 2015 | 20160826 | 20160407 | 20160902 | EXP | US-ROCHE-1731704 | ROCHE | 67.42 | YR | F | Y | 90.80000 | KG | 20160902 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122447013 | 12244701 | 1 | PS | ERIVEDGE | VISMODEGIB | 1 | Oral | 203388 | 150 | MG | QD | ||||||||
| 122447013 | 12244701 | 2 | SS | ERIVEDGE | VISMODEGIB | 1 | Oral | 203388 | 150 | MG | QD | ||||||||
| 122447013 | 12244701 | 3 | SS | ERIVEDGE | VISMODEGIB | 1 | Oral | 203388 | QD | ||||||||||
| 122447013 | 12244701 | 4 | SS | ERIVEDGE | VISMODEGIB | 1 | Oral | 203388 | QD | ||||||||||
| 122447013 | 12244701 | 5 | SS | DIAZEPAM. | DIAZEPAM | 1 | Oral | AS NEEDED | U | 13263 | 10 | MG | TID | ||||||
| 122447013 | 12244701 | 6 | C | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | Oral | PATIENT UNSURE OF DOSAGE AND START DATE | 0 | 120 | MG | TID | |||||||
| 122447013 | 12244701 | 7 | C | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | Oral | 0 | 120 | MG | QD | ||||||||
| 122447013 | 12244701 | 8 | C | QUINIDINE | QUINIDINE | 1 | Oral | PATIENT UNSURE OF DOSAGE AND START DATE | 0 | QD | |||||||||
| 122447013 | 12244701 | 9 | C | XARELTO | RIVAROXABAN | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 122447013 | 12244701 | 10 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Oral | PATIENT UNSURE OF DOSAGE AND START DATE | 0 | QD | |||||||||
| 122447013 | 12244701 | 11 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Sublingual | 0 | QD | ||||||||||
| 122447013 | 12244701 | 12 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Oral | 0 | 325 | MG | QD | ||||||||
| 122447013 | 12244701 | 13 | C | CLONIDINE. | CLONIDINE | 1 | Oral | 0 | |||||||||||
| 122447013 | 12244701 | 14 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 122447013 | 12244701 | 15 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 122447013 | 12244701 | 16 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | 0 | 40 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122447013 | 12244701 | 1 | Basal cell carcinoma |
| 122447013 | 12244701 | 5 | Anxiety |
| 122447013 | 12244701 | 6 | Blood pressure measurement |
| 122447013 | 12244701 | 8 | Blood pressure measurement |
| 122447013 | 12244701 | 9 | Anticoagulant therapy |
| 122447013 | 12244701 | 13 | Blood pressure measurement |
| 122447013 | 12244701 | 14 | Hypersensitivity |
| 122447013 | 12244701 | 15 | Neuropathy peripheral |
| 122447013 | 12244701 | 16 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122447013 | 12244701 | DS |
| 122447013 | 12244701 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122447013 | 12244701 | Abdominal pain upper | |
| 122447013 | 12244701 | Alopecia | |
| 122447013 | 12244701 | Anxiety | |
| 122447013 | 12244701 | Asthenia | |
| 122447013 | 12244701 | Bone disorder | |
| 122447013 | 12244701 | Cataplexy | |
| 122447013 | 12244701 | Decreased appetite | |
| 122447013 | 12244701 | Depression | |
| 122447013 | 12244701 | Diarrhoea | |
| 122447013 | 12244701 | Dysstasia | |
| 122447013 | 12244701 | Fall | |
| 122447013 | 12244701 | Fatigue | |
| 122447013 | 12244701 | Feeling abnormal | |
| 122447013 | 12244701 | Gait disturbance | |
| 122447013 | 12244701 | Gastric disorder | |
| 122447013 | 12244701 | Hypertension | |
| 122447013 | 12244701 | Hypoaesthesia | |
| 122447013 | 12244701 | Hypophagia | |
| 122447013 | 12244701 | Insomnia | |
| 122447013 | 12244701 | Movement disorder | |
| 122447013 | 12244701 | Muscle spasms | |
| 122447013 | 12244701 | Nausea | |
| 122447013 | 12244701 | Pharyngeal haemorrhage | |
| 122447013 | 12244701 | Sleep terror | |
| 122447013 | 12244701 | Thinking abnormal | |
| 122447013 | 12244701 | Thirst | |
| 122447013 | 12244701 | Tremor | |
| 122447013 | 12244701 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122447013 | 12244701 | 1 | 20160317 | 0 | ||
| 122447013 | 12244701 | 2 | 20160320 | 0 | ||
| 122447013 | 12244701 | 3 | 201109 | 0 | ||
| 122447013 | 12244701 | 4 | 201602 | 201606 | 0 | |
| 122447013 | 12244701 | 5 | 201603 | 0 | ||
| 122447013 | 12244701 | 7 | 2012 | 0 | ||
| 122447013 | 12244701 | 9 | 2015 | 0 | ||
| 122447013 | 12244701 | 12 | 2015 | 0 | ||
| 122447013 | 12244701 | 16 | 201607 | 0 |